Focal high-dose-rate brachytherapy: A dosimetric comparison of hemigland vs. conventional whole-gland treatment

被引:19
|
作者
Kamrava, Mitchell [1 ,2 ]
Chung, Melody P. [1 ]
Kayode, Oluwatosin [1 ]
Wang, Jason [1 ]
Marks, Leonard [3 ]
Kupelian, Patrick [1 ]
Steinberg, Michael [1 ,2 ]
Park, Sang-June [1 ]
Demanes, D. Jeffrey [1 ,2 ]
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiat Oncol, Los Angeles, CA 90095 USA
[2] Jonsson Comprehens Canc Ctr, Los Angeles, CA 90034 USA
[3] Univ Calif Los Angeles, David Geffen Sch Med, Dept Urol, Los Angeles, CA 90095 USA
关键词
Prostate; Focal therapy; Brachytherapy; LOCALIZED PROSTATE-CANCER; PHASE-II TRIAL; HDR BRACHYTHERAPY; RADICAL PROSTATECTOMY; RADIATION-THERAPY; FREE SURVIVAL; FOLLOW-UP; MONOTHERAPY; TOXICITY; CRYOABLATION;
D O I
10.1016/j.brachy.2012.09.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PURPOSE: To determine the utility of focal high-dose-rate brachytherapy for localized prostate cancer, we investigated the impact on target coverage and dose to organs at risk (OARs) with hemigland (HG) compared with whole-gland (WG) treatment. METHODS AND MATERIALS: A total of 10 WG implants were used to generate 10 WG and 20 HG (left and right) treatment plans optimized with the inverse planning simulation annealing algorithm using Oncentra MasterPlan (Nucletron B.V., Veenendaal, The Netherlands). The standard distribution of 17-18 catheters designed for WG was used to generate HG plans. The same OARs namely bladder, rectum, and urethra contours and dose constraints were applied for HG and WG plans. The HG contour was a modification of the WG contour whereby the urethra divided the prostate into HGs. The prescription dose was 7.25 Gy x 6. Evaluated dose parameters were target dose D-90, V-100, and V-150 and D-0.1 (cc) D-1 and D-2 (cc) to OARs. RESULTS: The HG plans had a D-90, V-100, and V-150 to the HG target of 112%, 97.6%, and 33.8%, respectively. The WG plans had a D-90, V-100, and V-150 to the WG target of 108%, 98.8%, and 26.5%, respectively. The OAR D-2 (cc) doses were significantly lower in HG vs. WG plans: rectum (53.1% vs. 64.1%, p<0.0001), bladder (55.9% vs. 67.5%, p<0.0001), and urethra (69.3% vs. 95.2%, p<0.0001). CONCLUSIONS: In the present model, HG plans yielded a statistically significant decreased radiation dose to OARs and provided complete target coverage with a catheter array designed for WG coverage. The good dosimetry results obtained in this study support the feasibility of HG brachytherapy by using a subset of the WG catheter array. Catheter distribution and dosimetry refinements tailored to subtotal prostate brachytherapy should be explored to see if further improvements in dosimetry can be achieved. (C) 2013 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:434 / 441
页数:8
相关论文
共 50 条
  • [41] High-dose-rate interstitial brachytherapy for the treatment of penile carcinoma
    Petera, J
    Odrázka, K
    Zouhar, M
    Bedrosová, J
    Dolezel, M
    STRAHLENTHERAPIE UND ONKOLOGIE, 2004, 180 (02) : 123 - 125
  • [42] High-dose-rate brachytherapy in the treatment of skin Kaposi sarcoma
    Gonzalez Ruiz, Maria Angeles
    Quiros Rivero, Juan
    Munoz Garcia, Julia Luisa
    Cabrera Rodriguez, Joaquin Jose
    Rios Kavadoy, Yesika
    Ropero Carmona, Maria Francisca
    Corbacho Campos, Almudena
    Garcia Urra, Fernando
    Cruz Munoz, Maria Cristina
    Ruiz Herrero, Amanda
    Almendral Manzano, Pedro
    JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 2017, 9 (06) : 561 - 565
  • [43] High-Dose-Rate Brachytherapy for the Treatment of Vaginal Intraepithelial Neoplasia
    Song, Jin Ho
    Lee, Joo Hwan
    Lee, Jong Hoon
    Park, Jong Sup
    Hong, Sook Hee
    Jang, Hong Seok
    Kim, Yeon Sil
    Choi, Byung Ock
    Yoon, Sei Chul
    CANCER RESEARCH AND TREATMENT, 2014, 46 (01): : 74 - 80
  • [44] Dosimetric characteristics of the 192Ir high-dose-rate afterloading brachytherapy source
    Sadeghi, Mahdi
    Taghdiri, Fatemah
    Saidi, Pooneh
    JAPANESE JOURNAL OF RADIOLOGY, 2011, 29 (05) : 324 - 329
  • [45] Dosimetric characteristics of the 192Ir high-dose-rate afterloading brachytherapy source
    Mahdi Sadeghi
    Fatemah Taghdiri
    Pooneh Saidi
    Japanese Journal of Radiology, 2011, 29 : 324 - 329
  • [46] High-dose-rate interstitial brachytherapy of Bartholin's gland: A case report
    Yamada, T
    Yanagawa, S
    Iwai, H
    Ishigaki, T
    Nawa, A
    Kikkawa, F
    GYNECOLOGIC ONCOLOGY, 2000, 77 (01) : 193 - 196
  • [47] Uterine perforation and its dosimetric implications in cervical cancer high-dose-rate brachytherapy
    Bahadur, Yasir A.
    Eltaher, Moho M.
    Hassouna, Ashraf H.
    Attar, Mohammad A.
    Constantinescu, Camelia
    JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 2015, 7 (01) : 41 - 47
  • [48] Comparison of dose and catheter optimization algorithms in prostate high-dose-rate brachytherapy
    Poulin, Eric
    Varfalvy, Nicolas
    Aubin, Sylviane
    Beaulieu, Luc
    BRACHYTHERAPY, 2016, 15 (01) : 102 - 111
  • [49] Dosimetric Evaluation of a Shielded Applicator for Use With Low Energy High-Dose-Rate Brachytherapy for Treatment of Ocular Melanoma
    Currier, B.
    Abramson, D. H.
    Zaider, M.
    Cohen, G. N.
    Munro, J. J.
    Medich, D. C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S269 - S269
  • [50] A fast multitarget inverse treatment planning strategy optimizing dosimetric measures for high-dose-rate (HDR) brachytherapy
    Guthier, Christian V.
    Damato, Antonio L.
    Viswanathan, Akila N.
    Hesser, Juergen W.
    Cormack, Robert A.
    MEDICAL PHYSICS, 2017, 44 (09) : 4452 - 4462